Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
indolequinone that is a bioreductiveprodrug and a chemicalanalogue of the olderchemotherapeutic agentmitomycin C.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word apaziquone.
Examples
-
He will be primarily responsible for leading and managing Spectrum's cross-functional brand efforts for FUSILEV ® and ZEVALIN® as well as brand planning for apaziquone and belinostat, Spectrum's late-stage drugs in development.
unknown title 2011
-
"We believe Dr. Holzer will be an immediate value-added member of the Spectrum Pharmaceuticals commercial organization as we continue to grow the FUSILEV and ZEVALIN brands and prepare for the additions of apaziquone and belinostat over the next 12-18 months," said Rajesh C.
unknown title 2011
-
The Company markets two oncology drugs, FUSILEV and ZEVALIN, and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.
-
The Company markets two oncology and hematology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.
unknown title 2011
-
The Company markets two oncology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.
unknown title 2011
-
The Company markets two oncology drugs, FUSILEV and ZEVALIN, and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.
unknown title 2011
-
And of course, happily given the other things we did in the last few years in terms of co-operations, we have the partnership with Spectrum Pharmaceuticals for apaziquone, we have the partnership with Serenity for the nocturia product.
unknown title 2011
-
The Company markets two oncology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.
Spectrum Pharmaceuticals to Develop Biosimilar Rituximab - Yahoo! Finance 2011
-
This compares to $8.1 million in consolidated revenue in the second quarter of 2009, which was comprised of $6.0 million from product sales ($3.3 million from ZEVALIN, $2.7 million from FUSILEV) and $2.1 million from amortization of the previously received apaziquone licensing fees.
-
The Company markets two oncology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.